More than half of adults who underwent chemotherapy for breast, gastrointestinal, gynecologic or lung cancer had confirmed hearing loss, and more than 35% had tinnitus, according to data published in BMJ Supportive & Palliative Care.
The associations were observed regardless of platinum- or taxane-containing chemotherapy regimens, Christine Miaskowski, RN, PhD, FAAN, professor and vice chair for research and Sharon Lamb Endowed Chair in Symptom Management Research at the University of California, San Francisco, and colleagues reported.
In light of the findings, Miaskowski said that primary